Preoperative clinical characteristics for differentiating malignant transformation from torsion of mature cystic teratoma

References

• Artunc Ulkumen, B., et al., 2013. Abnormal elevated CA 19-9 in the dermoid cyst: a sign of the ovarian torsion? Case Reports in Obstetrics and Gynecology, 860505.
   PubMedGoogle Scholar
• Balkwill, F. and Mantovani, A., 2001. Inflammation and cancer: back to Virchow? The Lancet, 357 (9255), 539–545.
   PubMed Web of Science ®Google Scholar
• Borner, C., et al., 2018. Pain mechanisms in peritoneal diseases might be partially regulated by estrogen. Reproductive Sciences, 25 (3), 424–434.
   PubMed Web of Science ®Google Scholar
• Chang, J. L., et al., 2010. Adenocarcinoma arising from mature cystic teratoma of the ovary. Journal of Medical Sciences, 22, 239–243.
   Google Scholar
• Chen, R. J., et al., 2008. Prognosis and treatment of squamous cell carcinoma from a mature cystic teratoma of the ovary. Journal of the Formosan Medical Association = Taiwan yi Zhi, 107 (11), 857–868.
   PubMed Web of Science ®Google Scholar
• Comerci, J. T., et al., 1994. Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature. Obstetrics and Gynecology, 84 (1), 22–28.
   PubMed Web of Science ®Google Scholar
• Conte, A., et al., 2020. Diagnostic and management of malignant transformation of ovarian mature teratoma. International Journal of Medical Reviews and Case Reports, 4 (10), 50–53.
   Google Scholar
• Curling, O. M., Potsides, P. N. and Hudson, C. N. J. B. J. O. O., & 1979. Malignant change in benign cystic teratoma of the ovary. British Journal of Obstetrics and Gynaecology, 86 (5), 399–402.
   PubMedGoogle Scholar
• Feng, Z., et al., 2016. Preoperative neutrophil-to-lymphocyte ratio as a predictive and prognostic factor for high-grade serous ovarian cancer. PLoS One, 11 (5), e0156101.
   PubMed Web of Science ®Google Scholar
• Goudeli, C., et al., 2017. An ovarian mature cystic teratoma evolving in squamous cell carcinoma: a case report and review of the literature. Gynecologic Oncology Reports, 19, 27–30.
   PubMed Web of Science ®Google Scholar
• Guven, S., et al., 2015. Is the measurement of serum ischemia-modified albumin the best test to diagnose ovarian torsion? Gynecologic and Obstetric Investigation, 79 (4), 269–275.
   PubMed Web of Science ®Google Scholar
• Hackethal, A., et al., 2008. Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data. The Lancet Oncology, 9 (12), 1173–1180.
   PubMed Web of Science ®Google Scholar
• Hufnagel, D. H., et al., 2020. Platelets, thrombocytosis, and ovarian cancer prognosis: surveying the landscape of the literature. International Journal of Molecular Sciences, 21, 8169.
   PubMed Web of Science ®Google Scholar
• Jamor, J., et al., 2020. Malignant transformation of ovarian mature teratoma: 04 cases report, review of the literature. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 9 (2), 819–824.
   Google Scholar
• Kikkawa, F., et al., 1997. Squamous cell carcinoma arising from mature cystic teratoma of the ovary: A clinicopathologic analysis. Obstetrics and Gynecology, 89 (6), 1017–1022.
   PubMed Web of Science ®Google Scholar
• Kikkawa, F., et al., 1998. Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary. Cancer, 82 (11), 2249–2255.
   PubMed Web of Science ®Google Scholar
• Koleli, I., 2015. Mean platelet volume in early diagnosis of adnexal torsion. Balkan Medical Journal, 32 (4), 410–413.
   PubMed Web of Science ®Google Scholar
• Kudva, R., Ayachit, G. S. and Ayachit, A. J. J. O. C., 2015. Malignant melanoma arising in an ovarian mature cystic teratoma - a rare entity. Journal of Clinical Diagnostic Research, 9, 14–16.
   Google Scholar
• Li, C., et al., 2019. Squamous cell carcinoma transformation in mature cystic teratoma of the ovary: a systematic review. BMC Cancer, 19 (1), 217.
   PubMedGoogle Scholar
• Mori, Y., et al., 2003. Preoperative diagnosis of malignant transformation arising from mature cystic teratoma of the ovary. Gynecologic Oncology, 90, 338–341.
   PubMed Web of Science ®Google Scholar
• Nakao, S., et al., 2020. Pretreatment thrombocytosis as an independent predictive factor for chemoresistance and poor survival in epithelial ovarian cancer. Journal of Ovarian Research, 13 (1), 55.
   PubMed Web of Science ®Google Scholar
• Nanki, Y., et al., 2017. Elevated preoperative neutrophil: lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation. The Journal of Obstetrics and Gynaecology Research, 43 (4), 744–748.
   PubMed Web of Science ®Google Scholar
• Nie, W., et al., 2017. Tumor-promoting effect of IL-23 in mammary cancer mediated by infiltration of M2 macrophages and neutrophils in tumor microenvironment. Biochemical and Biophysical Research Communications, 482 (4), 1400–1406.
   PubMed Web of Science ®Google Scholar
• O’Neill, J., Burns, P. and Kinsella, J., 2012. Papillary type thyroid carcinoma in an ovarian struma. Irish Journal of Medical Science, 181 (1), 115–117.
   PubMed Web of Science ®Google Scholar
• Opris, I., et al., 2009. Oligodendroglioma arising in an ovarian mature cystic teratoma. International Journal of Gynecological Pathology, 28, 367–371.
   PubMed Web of Science ®Google Scholar
• Park, J. Y., et al., 2008. Malignant transformation of mature cystic teratoma of the ovary: experience at a single institution. European Journal of Obstetrics & Gynecology and Reproductive Biology, 141 (2), 173–178.
   PubMed Web of Science ®Google Scholar
• Prodromidou, A., et al., 2017. The diagnostic efficacy of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in ovarian cancer. Inflammation Research, 66 (6), 467–475.
   PubMed Web of Science ®Google Scholar
• Qin, L., et al., 2021. Malignant transformation arising from mature ovarian cystic teratoma: a case series. Medicine, 100 (13), e24726.
   PubMed Web of Science ®Google Scholar
• Rim, S. Y., Kim, S. M. and Choi, H. S., 2006. Malignant transformation of ovarian mature cystic teratoma. International Journal of Gynecological Cancer, 16 (1), 140–144.
   PubMed Web of Science ®Google Scholar
• Santos, L. D., et al., 2007. Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature. Gynecologic Oncology, 105 (2), 321–324.
   PubMed Web of Science ®Google Scholar
• Saunders, A. M. and Hertzman, V. O., 1960. Malignant carcinoid teratoma of the ovary. Canadian Medical Association Journal, 83 (11), 602–605.
   PubMedGoogle Scholar
• Seizer, P., May, A. E., and Haemostasis , 2013. Platelets and matrix metalloproteinases. Thrombosis and Haemostasis, 110 (5), 903–909.
   PubMed Web of Science ®Google Scholar
• Wang, Y. Q., et al., 2016. A novel prognostic inflammation score predicts outcomes in patients with ovarian cancer. Clinica Chimica Acta; International Journal of Clinical Chemistry, 456, 163–169.
   PubMed Web of Science ®Google Scholar
• Wang, Y. Q., et al., 2017. Use of cancer antigen 125, cancer antigen 19-9, and the neutrophil-to-lymphocyte ratio to diagnose mature cystic teratoma with torsion. International Journal of Gynaecology and Obstetrics, 137 (3), 332–337.
   PubMed Web of Science ®Google Scholar
• White, M. and Stella, J., 2005. Ovarian torsion: 10-Year perspective. Emergency Medicine Australasia, 17 (3), 231–237.
   PubMedGoogle Scholar
• Yan, F. C., et al., 2015. Ovarian carcinoid with mature teratoma of the ovary: report of two cases and literature review. Chinese Journal of Diagnostic Pathology, 22 (12), 761–764.
   Google Scholar
• Yin, X., et al., 2019. Prognostic significance of neutrophil–lymphocyte ratio (NLR) in patients with ovarian cancer: a systematic review and meta-analysis. Medicine, 98 (45), e17475.
   PubMed Web of Science ®Google Scholar
• 박미선 2007. A case of sarcoma arising in ovarian mature cystic teratoma. 대한산부인과학회 학술발표논문집, 93, 219.
   Google Scholar